Evidence map›Paper›PMID 42388581›Full record

ArticleCancer diagnosis & prognosis

Cancer of Unknown Primary Most Suggestive of Colorectal Origin With Microsatellite Instability-high Status and High Tumor Mutation Burden Including NTRK Fusion.

Hirofumi Sato, Masatsugu Hiraki, Tomonori Shimonishi, Yukari Takase, Natsuko Komiya, Chiho Nakashima, Hiroyuki Irie, Yoshito Akagi, Naoko Aragane

Abstract read
In one paragraph

Article in Cancer diagnosis & prognosis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hirofumi SatoDepartment of Surgery, Takagi Hospital, Okawa, Japan.
Masatsugu HirakiDepartment of Surgery, Takagi Hospital, Okawa, Japan.
Tomonori ShimonishiDepartment of Surgery, Takagi Hospital, Okawa, Japan.
Yukari TakaseDepartment of Pathology, Takagi Hospital, Okawa, Japan.
Natsuko KomiyaDivision of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
Chiho NakashimaDivision of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.
Hiroyuki IrieDepartment of Radiology, Takagi Hospital, Okawa, Japan.
Yoshito AkagiDepartment of Surgery, Takagi Hospital, Okawa, Japan.
Naoko AraganeCancer Center, Takagi Hospital, Okawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/Aim: Cancer of unknown primary (CUP) is associated with a poor prognosis. Recent advances in comprehensive genomic profiling (CGP) have made it possible to detect actionable mutations in CUP cases, which allows the inference of the primary tumor site. This report demonstrates CUP most suggestive of colorectal origin and highlights how CGP can significantly impact treatment decisions and outcomes. Case Report: A 73-year-old woman presented with altered consciousness secondary to diabetic ketoacidosis. Imaging revealed a huge mass with abscess formation near the hepatic flexure, but colonoscopy and biopsy failed to identify a definitive primary site. The histopathology of echo-guided percutaneous tumor biopsy showed poorly differentiated adenocarcinoma. Immunohistochemistry revealed that it was positive for cytokeratin (CK) 7, negative for CK20, and slightly positive for caudal type homeobox (CDX) 2. Although colorectal cancer was the most suspected diagnosis based on imaging examination, the patient was still diagnosed with CUP and treated with carboplatin and nab-paclitaxel, resulting in a partial response; however, treatment was discontinued due to adverse effects. CGP revealed microsatellite instability (MSI)-high, high tumor mutation burden (TMB) of 100/Mb, and neurotrophic tropomyosin receptor tyrosine kinase ( Conclusion: CUP is generally associated with poor prognosis. Comprehensive genomic profiling (CGP) offers a promising avenue for discovering personalized and potentially effective therapeutic strategies.

Indexed as

CGPcolon cancerCUPlarotrectinibMSI-highTPM3-NTRK1

Identifiers

PMID42388581
PMCPMC13321928

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.